# Novo Nordisk (NVO) SEC filings: latest 20-F and 6-K

URL: https://funkfolio.com/stock/NVO/filings

> Novo Nordisk (NVO) SEC filings from EDGAR: 20-F filed Feb 4, 2026, 6-K filed Nov 16, 2026. 81 filings in the last 12 months, with insider and ownership forms.

---

## Novo Nordisk (NVO) SEC filings

Novo Nordisk's latest annual report is a Form 20-F filed on February 4, 2026 for the period ended December 31, 2025. Its latest Form 6-K report was filed on November 16, 2026. EDGAR lists 81 filings for it in the last twelve months.

### Key facts

- **Latest annual report:** 20-F, Feb 4, 2026
- **Latest 6-K:** 6-K, Nov 16, 2026
- **Filings, last 12 months:** 81
- **Insider forms, last 12 months:** 0 Forms 3, 4 and 5
- **13D and 13G, last 12 months:** 3
- **SEC central index key:** 0000353278

Filings as listed by SEC EDGAR at Nov 18, 2026, 10:46 UTC (re-read at most hourly). Source: [SEC EDGAR filings for CIK 0000353278](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000353278). Every form links to its document on sec.gov. Older filings are in EDGAR's archive; the tables here cover its recent list (at least the last year).

### Annual and quarterly reports

Novo Nordisk: annual and quarterly reports filed with the SEC

| Form | Filed | Period ended | Document |
| --- | --- | --- | --- |
| [20-F](https://www.sec.gov/Archives/edgar/data/353278/000035327826000012/nvo-20251231.htm) | Feb 4, 2026 | Dec 31, 2025 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/353278/000162828025003920/nvo-20241231.htm) | Feb 5, 2025 | Dec 31, 2024 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/353278/000162828024002635/nvo-20231231.htm) | Jan 31, 2024 | Dec 31, 2023 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/353278/000162828023001868/nvo-20221231.htm) | Feb 1, 2023 | Dec 31, 2022 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/353278/000162828022001639/nvo-20211231.htm) | Feb 2, 2022 | Dec 31, 2021 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/353278/000162828021001364/novo-b20xf12x31x20.htm) | Feb 3, 2021 | Dec 31, 2020 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/353278/000162828020001021/novo-b20xf12x31x19.htm) | Feb 5, 2020 | Dec 31, 2019 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/353278/000162828019000875/novo-b20xf12x31x18.htm) | Feb 4, 2019 | Dec 31, 2018 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/353278/000162828018001266/novo-b20xf12x31x17.htm) | Feb 8, 2018 | Dec 31, 2017 | Annual report of a foreign private issuer |
| [20-F](https://www.sec.gov/Archives/edgar/data/353278/000117184317000780/f20f_020917.htm) | Feb 9, 2017 | Dec 31, 2016 | FORM 20-F |

Amended reports are marked. The period is the fiscal year or quarter the report covers.

#### Reports of a foreign private issuer (Form 6-K)

Novo Nordisk: reports on Form 6-K

| Form | Filed | Report date | Document |
| --- | --- | --- | --- |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326007470/f6k_111626.htm) | Nov 16, 2026 | Nov 16, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326007260/f6k_110926.htm) | Nov 9, 2026 | Nov 9, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326007156/f6k_110526.htm) | Nov 5, 2026 | Nov 5, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000162828026069805/caq32026.htm) | Nov 4, 2026 | Sep 30, 2026 | Report of a foreign private issuer |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326007060/f6k_110326.htm) | Nov 3, 2026 | Nov 3, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326006813/f6k_102626.htm) | Oct 26, 2026 | Oct 26, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326006685/f6k_101926.htm) | Oct 19, 2026 | Oct 19, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326006585/f6k_101226.htm) | Oct 13, 2026 | Oct 12, 2023 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326006440/f6k_100526.htm) | Oct 6, 2026 | Oct 5, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326006374/f6k_100226.htm) | Oct 5, 2026 | Oct 2, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326006248/f6k_092826.htm) | Sep 28, 2026 | Sep 28, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326006128/f6k_092126.htm) | Sep 21, 2026 | Sep 21, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326006088/f6k_091726.htm) | Sep 17, 2026 | Sep 17, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326006038/f6k_091426.htm) | Sep 15, 2026 | Sep 14, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326005925/f6k_090726.htm) | Sep 9, 2026 | Sep 7, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326005795/f6k_083126.htm) | Aug 31, 2026 | Aug 31, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326005715/f6k_082426.htm) | Aug 24, 2026 | Aug 24, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326005599/f6k_081726.htm) | Aug 18, 2026 | Aug 17, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326005376/f6k_081026.htm) | Aug 10, 2026 | Aug 10, 2026 | FORM 6-K |
| [6-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326005375/f6k_080626.htm) | Aug 10, 2026 | Aug 6, 2026 | FORM 6-K |

The latest 20 of 895 in EDGAR's recent list. A 6-K carries what the company publishes at home — results, press releases, notices to shareholders.

### Ownership reports (Schedules 13D and 13G)

Novo Nordisk: Schedule 13D and 13G beneficial ownership reports

| Form | Filed | Event date |
| --- | --- | --- |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010326009261/xslSCHEDULE_13G_X02/primary_doc.xml) | Jun 22, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010326005593/xslSCHEDULE_13G_X02/primary_doc.xml) | Apr 10, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010326003227/xslSCHEDULE_13G_X01/primary_doc.xml) | Mar 4, 2026 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010325013417/xslSCHEDULE_13G_X01/primary_doc.xml) | Oct 21, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000205211325001421/xslSCHEDULE_13G_X01/primary_doc.xml) | Apr 23, 2025 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000108636424006715/dk0060534915_020624.txt) | Feb 6, 2024 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000130655023008717/dk0060534915_02323.txt) | Feb 23, 2023 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000083423722004098/dk0060534915_012822.txt) | Feb 1, 2022 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000083423721004593/dk0060534915_012921.txt) | Jan 29, 2021 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000083423720006032/dk0060534915_020520.txt) | Feb 5, 2020 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/353278/000095010320001698/dp119689_sc13g.htm) | Feb 3, 2020 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000021545719004916/dk0060534915_020519.txt) | Feb 6, 2019 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010319000893/dp101239_sc13ga3.htm) | Jan 25, 2019 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/353278/000095010318014866/dp99852_sc13g.htm) | Dec 21, 2018 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010318001711/dp86507_sc13ga2.htm) | Feb 8, 2018 | — |
| [Schedule 13G](https://www.sec.gov/Archives/edgar/data/353278/000021545718004506/dk0060534915_013118.txt) | Feb 1, 2018 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010317000601/dp72036_sc13ga1.htm) | Jan 25, 2017 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000021545716006745/novo.nordisk.as.c.txt) | Sep 9, 2016 | — |
| [Schedule 13G (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010316014163/dp66522_sc13ga.htm) | Jun 16, 2016 | — |

Filed by the holder, not the company. EDGAR's list names the form and date; who filed it is in the document.

**Everything else (76 filings: registrations, prospectuses, Rule 144 notices, correspondence and more)**

Novo Nordisk: other SEC filings

| Form | Filed | Period | Document |
| --- | --- | --- | --- |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326004205/nvo20251231c_11k.htm) | Jun 22, 2026 | Dec 31, 2025 | FORM 11-K |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/000117184326004204/nvo20251231_11k.htm) | Jun 22, 2026 | Dec 31, 2025 | FORM 11-K |
| [SD](https://www.sec.gov/Archives/edgar/data/353278/000095010326007633/dp247116_sd.htm) | May 22, 2026 | — | FORM SD |
| [IRANNOTICE](https://www.sec.gov/Archives/edgar/data/353278/000035327826000014/irannotice2025.htm) | Feb 4, 2026 | — |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/000117184325004172/nvo20241231c_11k.htm) | Jun 27, 2025 | Dec 31, 2024 | FORM 11-K |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/000117184325004170/nvo20241231_11k.htm) | Jun 27, 2025 | Dec 31, 2024 | FORM 11-K |
| [144](https://www.sec.gov/Archives/edgar/data/353278/000095010325006700/xsl144X01/primary_doc.xml) | May 30, 2025 | — | Notice of proposed sale |
| [SD](https://www.sec.gov/Archives/edgar/data/353278/000095010325006325/dp229141_sd.htm) | May 22, 2025 | — | FORM SD |
| [IRANNOTICE](https://www.sec.gov/Archives/edgar/data/353278/000162828025004542/irannotice2024.htm) | Feb 10, 2025 | — |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/000117184324003561/f11k_062024.htm) | Jun 21, 2024 | Dec 31, 2023 | FORM 11-K |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/000117184324003560/f11k_061824.htm) | Jun 21, 2024 | Dec 31, 2023 | FORM 11-K |
| [SD](https://www.sec.gov/Archives/edgar/data/353278/000095010324006805/dp211308_sd.htm) | May 17, 2024 | — | FORM SD |
| [IRANNOTICE](https://www.sec.gov/Archives/edgar/data/353278/000162828024002637/irannotice2023.htm) | Jan 31, 2024 | — |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/353278/000000000023013131/filename1.pdf) | Dec 1, 2023 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/353278/000095010323016602/filename1.htm) | Nov 24, 2023 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/353278/000095010323016118/filename1.htm) | Nov 9, 2023 | — |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/353278/000000000023012049/filename1.pdf) | Nov 3, 2023 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/353278/000095010323015174/filename1.htm) | Oct 20, 2023 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/353278/000095010323014246/filename1.htm) | Sep 29, 2023 | — |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/353278/000000000023010652/filename1.pdf) | Sep 27, 2023 | — |  |
| [EFFECT](https://www.sec.gov/Archives/edgar/data/353278/999999999523002653/xslEFFECTX01/primary_doc.xml) | Sep 13, 2023 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/353278/000095010323013525/filename1.htm) | Sep 13, 2023 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/353278/000095010323013164/filename1.htm) | Sep 5, 2023 | — |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/353278/000000000023009666/filename1.pdf) | Aug 31, 2023 | — |  |
| [F-6](https://www.sec.gov/Archives/edgar/data/353278/000110465923097162/tm2325214d1_f6.htm) | Aug 31, 2023 | — | FORM F-6 |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/000117184323004177/f11k_062723.htm) | Jun 27, 2023 | Dec 31, 2022 | FORM 11-K |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/000117184323004176/f11k_062723.htm) | Jun 27, 2023 | Dec 31, 2022 | FORM 11-K |
| [SD](https://www.sec.gov/Archives/edgar/data/353278/000095010323007614/dp194087_sd.htm) | May 23, 2023 | — | FORM SD |
| [IRANNOTICE](https://www.sec.gov/Archives/edgar/data/353278/000162828023001870/irannotice2022.htm) | Feb 1, 2023 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/353278/000119312522262658/d398311dsctota.htm) | Oct 14, 2022 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/353278/000119312522259256/d514098dsctota.htm) | Oct 7, 2022 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010322016541/dp181230_sctota.htm) | Sep 28, 2022 | — | AMENDMENT NO. 1 |
| [SC TO-T](https://www.sec.gov/Archives/edgar/data/353278/000119312522245731/d380569dsctot.htm) | Sep 15, 2022 | — |  |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/353278/000095010322015137/dp179779_sctoc.htm) | Sep 1, 2022 | — | FORM SC TO-C |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/999999999722003514/novo2.pdf) | Jun 28, 2022 | Dec 31, 2021 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/999999999722003513/novo1.pdf) | Jun 28, 2022 | Dec 31, 2021 |  |
| [SD](https://www.sec.gov/Archives/edgar/data/353278/000095010322009660/dp173663_sd.htm) | May 31, 2022 | — | FORM SD |
| [S-8](https://www.sec.gov/Archives/edgar/data/353278/000119312522083498/d300057ds8.htm) | Mar 24, 2022 | — | Registration statement for employee plans |
| [IRANNOTICE](https://www.sec.gov/Archives/edgar/data/353278/000162828022001641/irannotice1.htm) | Feb 2, 2022 | — |  |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010321020298/dp164122_sctota3.htm) | Dec 28, 2021 | — | FORM SC TO-T/A |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010321020223/dp164121_sctota2.htm) | Dec 27, 2021 | — | FORM SC TO-T/A |
| [SC TO-T (amended)](https://www.sec.gov/Archives/edgar/data/353278/000095010321019455/dp163313_sctota.htm) | Dec 8, 2021 | — | FORM SC TO-T/A |
| [SC TO-T](https://www.sec.gov/Archives/edgar/data/353278/000119312521340445/d266395dsctot.htm) | Nov 24, 2021 | — |  |
| [SC TO-C](https://www.sec.gov/Archives/edgar/data/353278/000095010321018083/dp161916_sctoc.htm) | Nov 18, 2021 | — | FORM SC TO-C |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/999999999721003683/nord2.pdf) | Jun 23, 2021 | Dec 31, 2020 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/999999999721003682/nord11k.pdf) | Jun 23, 2021 | Dec 31, 2020 |  |
| [SD](https://www.sec.gov/Archives/edgar/data/353278/000095010321007947/dp151858_sd.htm) | May 27, 2021 | — | FORM SD |
| [IRANNOTICE](https://www.sec.gov/Archives/edgar/data/353278/000162828021001366/irannotice.htm) | Feb 3, 2021 | — |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/999999999720003763/novo401k.pdf) | Jun 25, 2020 | Dec 31, 2019 |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/999999999720003762/novo11k.pdf) | Jun 25, 2020 | Dec 31, 2019 |  |
| [SD](https://www.sec.gov/Archives/edgar/data/353278/000095010320010268/dp128942_sd.htm) | May 28, 2020 | — | FORM SD |
| [IRANNOTICE](https://www.sec.gov/Archives/edgar/data/353278/000162828020001023/irannotice.htm) | Feb 5, 2020 | — |  |
| [11-K](https://www.sec.gov/Archives/edgar/data/353278/999999999719005831/novo11k62119.pdf) | Jun 21, 2019 | Dec 31, 2018 |  |
| [SD](https://www.sec.gov/Archives/edgar/data/353278/000095010319006682/dp109085_sd.htm) | May 22, 2019 | — | FORM SD |
| [IRANNOTICE](https://www.sec.gov/Archives/edgar/data/353278/000162828019000877/irannotice.htm) | Feb 4, 2019 | — |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/353278/000000000018035929/filename1.pdf) | Nov 20, 2018 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/353278/000095010318012478/filename1.htm) | Oct 26, 2018 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/353278/000095010318010212/filename1.htm) | Aug 31, 2018 | — |  |
| [CORRESP](https://www.sec.gov/Archives/edgar/data/353278/000095010318009629/filename1.htm) | Aug 14, 2018 | — |  |
| [UPLOAD](https://www.sec.gov/Archives/edgar/data/353278/000000000018024396/filename1.pdf) | Aug 7, 2018 | — |  |

The latest 60 of 76 in EDGAR's recent list.

### What the forms are

**Form 4 — Statement of changes in beneficial ownership**

An insider's transactions in the company's equity securities, disclosed within two business days of the transaction.

**Form 144 — Notice of proposed sale**

In the SEC's Forms Index: notice of proposed sale of securities pursuant to Rule 144.

**Form 10-K — Annual report**

Audited annual financial statements, a discussion of material risk factors, and management's discussion and analysis of the results for the prior fiscal year.

**Form 10-Q — Quarterly report**

Unaudited quarterly financial statements, updates on material risks, and management's discussion and analysis of the results for the prior fiscal quarter.

**Form 8-K — Current report**

Discloses material events or information the company chooses or is required to make public before its next scheduled quarterly or annual report. Each report lists the items it covers.

**Form 20-F — Annual report of a foreign private issuer**

Audited financial statements of the foreign private issuer and a discussion of its financial results; the same form is used to register a class of securities.

**Form 6-K — Report of a foreign private issuer**

Filed with press releases, communications to security holders, and disclosures the company's home country requires it to make to security holders.

**Schedule 13G — Schedule 13G beneficial ownership report**

Filed when a party acquires more than five percent of a class of the company's registered voting securities as a passive investment.

**Form S-8 — Registration statement for employee plans**

In the SEC's Forms Index: registration statement under the Securities Act of 1933 for securities to be offered to employees under certain plans.

**Form SD — Specialized disclosure report**

In the SEC's Forms Index: Specialized Disclosure Report.

From the SEC's own descriptions: [SEC, Using EDGAR to Research Investments](https://www.sec.gov/search-filings/edgar-search-assistance/using-edgar-research-investments); [SEC, Forms Index](https://www.sec.gov/submit-filings/forms-index); [SEC, Form 8-K and its items (PDF)](https://www.sec.gov/files/form8-k.pdf).

### Questions and answers

**Where is Novo Nordisk's latest annual report (20-F)?**

Novo Nordisk filed its latest Form 20-F with the SEC on February 4, 2026 for the period ended December 31, 2025. The table of annual and quarterly reports on this page links to the document on sec.gov.

**How many insider filings (Forms 3, 4 and 5) were there for NVO in the last year?**

0 insider forms in the twelve months to November 18, 2026. Officers, directors and holders of more than 10 percent of a class of the company's registered equity securities must disclose their holdings and transactions; a Form 4 is due within two business days of a trade.

**Has anyone reported owning more than 5% of Novo Nordisk?**

EDGAR lists 3 Schedule 13D or 13G filings about Novo Nordisk in the last twelve months, the latest on June 22, 2026. These are filed by a party that acquires more than five percent of a class of the company's voting securities; 13G is for passive investors.

### Learn

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Novo Nordisk (NVO) SEC filings: latest 20-F and 6-K”, data as of 18 November 2026. https://funkfolio.com/stock/NVO/filings

Underlying data: SEC EDGAR submissions (data.sec.gov).
